Azamian Bobak R. bought TARS

March 5, 2026 · Form 4 insider transaction

Azamian Bobak R. bought 60,776 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
60,776
Price
$0.00
Total value
N/A
Role
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after60,776
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.; The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.

View the original Form 4 on SEC EDGAR